Beobachtungsplan, NIS 733: Enhanced passive safety surveillance of VaxigripTetra® (quadrivalent inactivated split virion influenza vaccine, intramuscular route), Efluelda® (high dose quadrivalent inactivated split virion influenza vaccine, intramuscular route) and Supemtek® (quadrivalent recombinant influenza vaccine, intramuscular route) vaccines in Europe during the influenza season 2023/24.

Datei

• Artikel "Beobachtungsplan, NIS 733: Enhanced passive safety surveillance of VaxigripTetra® (quadrivalent inactivated split virion influenza vaccine, intramuscular route), Efluelda® (high dose quadrivalent inactivated split virion influenza vaccine, intramuscular route) and Supemtek® (quadrivalent recombinant influenza vaccine, intramuscular route) vaccines in Europe during the influenza season 2023/24."Herunterladen(PDF, 707KB, Datei ist nicht barrierefrei)